Acumen Pharmaceuticals Debt-to-Assets Ratio Growth & History (ABOS)

Acumen Pharmaceuticals's debt-to-assets ratio was 0.25 for fiscal 2025.

View full Acumen Pharmaceuticals company overview

Acumen Pharmaceuticals annual debt-to-assets ratio history

Acumen Pharmaceuticals annual debt-to-assets ratio

Fiscal yearPeriod endedDebt-to-assets ratioChangeGrowth
20252025-12-310.250.13+105.11%
20242024-12-310.120.02+24.14%
20232023-12-310.100.10+18643.40%
20222022-12-310.000.00
20212021-12-310.00

Acumen Pharmaceuticals debt-to-assets ratio trends

Between the periods ended 2021-12-31 and 2025-12-31, Acumen Pharmaceuticals's debt-to-assets ratio increased from 0.00 to 0.25, a change of 0.25. The latest reported quarter, Q2 2026, shows 0.27.

About the metric

What the debt-to-assets ratio means

The debt-to-assets ratio shows the portion of a company’s reported assets financed with interest-bearing debt. It is a leverage measure and should not be confused with total liabilities divided by assets.

Calculation and source

How debt-to-assets is calculated

TickerStat calculates debt-to-assets as total interest-bearing debt divided by total assets at the same reporting-period end. Periods with missing debt or non-positive assets are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Acumen Pharmaceuticals source filings ↗

Community posts

It’s quiet here.

No posts about ABOS yet. Start the conversation.

Write the first post